Skip to content

OS Therapies OSTX Investment Income Interest

Investment Income Interest at other companies

CTO
Citius Oncology, Inc.CTOR
$43.72K+381%

Segments

By segment

See full
Chief Operating Decision Maker$45-31.8%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's investment income interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's investment income interest?
OS Therapies (OSTX) reported investment income interest of $45 in Q1 2026.
How has OS Therapies's investment income interest changed year-over-year?
OS Therapies's investment income interest decreased by 31.8% year-over-year, from $66 to $45.
What does investment income interest mean?
Reflects the interest income earned on cash balances, marketable securities, or other short-term investments. This metric provides insight into the company's treasury management and the yield generated from its liquid assets.